HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Davide Bimbatti Selected Research

Duration of Therapy

10/2022Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses.
1/2017The incidence and relative risk of pulmonary toxicity in patients treated with anti-PD1/PD-L1 therapy for solid tumors: a meta-analysis of current studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Davide Bimbatti Research Topics

Disease

29Renal Cell Carcinoma (Grawitz Tumor)
04/2024 - 04/2015
15Neoplasms (Cancer)
01/2024 - 10/2016
13Prostatic Neoplasms (Prostate Cancer)
01/2024 - 01/2015
6Disease Progression
03/2024 - 01/2021
6Neoplasm Metastasis (Metastasis)
03/2024 - 12/2018
5Carcinoma (Carcinomatosis)
01/2024 - 02/2019
4Kidney Neoplasms (Kidney Cancer)
03/2024 - 01/2021
2Brain Neoplasms (Brain Tumor)
01/2024 - 01/2023
2Hypertension (High Blood Pressure)
02/2023 - 01/2018
2Neutropenia
02/2023 - 01/2023
2Anemia
01/2023 - 10/2022
2Cardiotoxicity
01/2019 - 01/2018
1Lymphatic Metastasis
01/2024
1Cognitive Dysfunction
01/2024
1Inflammation (Inflammations)
08/2023
1Diarrhea
02/2023
1Hyponatremia
02/2023
1Stomatitis
02/2023
1Body Weight (Weight, Body)
01/2023
1Thrombocytopenia (Thrombopenia)
01/2023
1Nausea
01/2023
1Mucositis
01/2023
1Headache (Headaches)
01/2023
1Constipation
01/2023
1Fatigue
01/2023
1Melanoma (Melanoma, Malignant)
02/2022
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2022
1Pain (Aches)
12/2020
1Frailty
10/2020
1Left Ventricular Dysfunction
01/2019
1Synovial Sarcoma (Synovioma)
11/2015
1Metabolic Diseases (Metabolic Disease)
11/2015
1Hypertriglyceridemia
11/2015
1Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome)
11/2015

Drug/Important Bio-Agent (IBA)

10Immune Checkpoint InhibitorsIBA
03/2024 - 11/2018
8cabozantinibIBA
02/2023 - 01/2019
7NivolumabIBA
04/2024 - 01/2021
7Tyrosine Kinase InhibitorsIBA
03/2024 - 01/2021
4abirateroneIBA
06/2023 - 01/2018
4enzalutamideIBA
06/2023 - 01/2015
3Sunitinib (Sutent)FDA Link
01/2024 - 04/2015
3Androgen Receptors (Androgen Receptor)IBA
12/2022 - 01/2015
2pazopanibFDA Link
01/2024 - 01/2021
2EverolimusFDA Link
01/2024 - 01/2022
2PlatinumIBA
01/2023 - 02/2019
2Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 - 10/2022
2Monoclonal AntibodiesIBA
01/2022 - 01/2017
2Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2016
2Hormones (Hormone)IBA
10/2018 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 11/2015
1Axitinib (AG 013736)IBA
03/2024
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2024
1avelumabIBA
03/2024
1Hemoglobins (Hemoglobin)IBA
01/2024
14-toluenesulfonyl fluoride (TSF)IBA
01/2024
1tributyl phosphate (TBP)IBA
01/2024
1lenvatinibIBA
01/2024
1Thyroid HormonesIBA
10/2023
1Creatine Kinase (Creatine Phosphokinase)IBA
02/2023
1niraparibIBA
01/2023
1Bevacizumab (Avastin)FDA Link
01/2023
1Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023
1IpilimumabIBA
10/2022
1talazoparibIBA
10/2022
1Sorafenib (BAY 43-9006)FDA Link
01/2022
1Programmed Cell Death 1 ReceptorIBA
01/2022
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2021
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
01/2021
1Angiogenesis InhibitorsIBA
01/2021
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
01/2021
1tivozanibIBA
01/2021
1Analgesics (Analgesic Drugs)IBA
12/2020
1Prostate-Specific Antigen (Semenogelase)IBA
12/2020
1B7-H1 AntigenIBA
01/2019
1AndrogensIBA
10/2018
1Docetaxel (Taxotere)FDA Link
10/2018
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2017
1Platinum Compounds (Compounds, Platinum)IBA
10/2016
1Adenosine Diphosphate (ADP)IBA
10/2016
1Adenosine Diphosphate Ribose (ADP-Ribose)IBA
10/2016
1Succinate Dehydrogenase (Fumarate Reductase)IBA
11/2015
1Epidermal Growth Factor (EGF)IBA
11/2015
1Glucose (Dextrose)FDA LinkGeneric
11/2015
1Oxygen (Dioxygen)IBA
11/2015
1Fumarate Hydratase (Fumarase)IBA
11/2015
1Ferritins (Ferritin)IBA
11/2015
1Fibrinogen (Factor I)FDA Link
11/2015
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2015

Therapy/Procedure

17Therapeutics
03/2024 - 04/2015
13Immunotherapy
04/2024 - 11/2018
9Castration
06/2023 - 01/2015
5Drug Therapy (Chemotherapy)
01/2024 - 11/2015
3Nephrectomy
03/2024 - 09/2022
2Duration of Therapy
10/2022 - 01/2017
1Activities of Daily Living (ADL)
01/2024
1Self Administration (Administration, Self)
12/2022
1Retreatment
02/2022
1Palliative Care (Palliative Therapy)
01/2022
1Hematopoietic Stem Cell Transplantation
01/2022
1Precision Medicine
10/2016